Thomas Pike - Iqvia Holdings CEO and Director

Mr. Thomas H. Pike serves as Vice Chairman of the Board President, Research Development Solutions of the Company. He was Chief Executive Officer of Quintiles Transnational Holdings Inc. Mr. Pike has served as Chief Executive Officer of Quintiles Transnational since April 2012, as a director since August 2012 and as our Chief Executive Officer since January 2013. Mr. Pike served as Chief Executive Officer of Accelion, Inc., a healthcare outsourcing firm, from January 2010 to November 2010. Following his service with Accelion, Inc., Mr. Pike acted as an independent consultant. Mr. Pike previously spent 22 years with Accenture, a global management consulting, technology services and outsourcing company, including serving as Chief Risk Officer from September 2009 to January 2010, Managing DirectorNorth America Health and Products Industries from December 2006 to August 2009, Chief Operating OfficerGlobal Resources Industries from March 2002 to December 2006 and Managing PartnerGrowth Strategy from 1999 until March 2002. Mr. Pike began his career in the consulting industry, including as a Senior Engagement Manager with McKinsey Company from 1989 to 1992
Age: 56  CEO Since 2016      
Pike received his BS in Accounting from the University of Delaware.

Thomas Pike Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Iqvia Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Found 9 records

CEO Since

Satya NadellaMicrosoft Corporation
Tim CookApple
Lamberto AndreottiBristol Myer Squi Pf
Zhaoxi LuAlibaba Group Holding Limited
Sundar PichaiAlphabet
Timothy CookApple
Yong ZhangAlibaba Group Holding Limited
Larry PageAlphabet

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Iqvia Holdings (Q) is traded on BATS Exchange in USA and employs 36,100 people.

Iqvia Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

Iqvia Holdings Investor Sentiment

More than half of Macroaxis users are at this time bullish on Iqvia Holdings. What is your judgment towards investing in Iqvia Holdings? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Purchased few shares of
a day ago
Traded for 185.37
Purchased few shares of
a day ago
Traded for 194.88
Purchased few shares of
a day ago
Traded for 1350.8199
Purchased over 100 shares of
a day ago
Traded for 30.5
Purchased a lot of shares of
a day ago
Traded for 154.6
See also Your Equity Center. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.